Elevation Capital's $500M Fund IX Bets on India's AI App Layer

Elevation Capital just closed a $500M fund to back seed and Series A AI startups in India, and paired it with a $400M late-stage vehicle for $900M in total firepower. Check sizes at the earliest stage have roughly doubled to as much as $10M as the firm chases India's "AI app layer" instead of foundation models. I think the thesis is sound, but the timing sits uncomfortably close to warnings from India's own central bank about AI valuation risk.

Elevation Capital closed its ninth flagship fund, Fund IX, at $500M on July 14, according to The Economic Times, which reported the fund will focus on seed and Series A startups building on what the firm calls AI's "app layer" — the products that sit on top of large language models rather than the models themselves. Inc42 confirmed the same $500M figure and corpus structure independently, so this isn't a single-source number. Elevation didn't stop there. It paired Fund IX with a separate $400M vehicle, Elevation Holdings, dedicated to late-stage bets, giving the Mumbai-based firm roughly $900M in fresh capital to deploy across the full lifecycle of an Indian AI startup, from first check to growth round.

If you've watched Indian venture capital for the past decade, Elevation is not a new name doing a new thing. It's an old name (founded in 2001 as SAIF Partners, rebranded in 2020) doing the thing it's always done, just bigger and narrower at once. The firm has backed Paytm, Swiggy, Urban Company, Meesho, FirstCry, Wakefit, and Ixigo. It has around $2.6B in assets under management, a portfolio north of 190 companies, and something between 5 and 13 companies it counts as unicorns depending on how you draw the line. It has also produced 30 IPOs and 38 acquisitions, including the sale of AI infrastructure startup Portkey to Palo Alto Networks. This is not a firm chasing headlines. It's a firm with a two-decade track record now betting that the next decade of returns in India comes from AI applications, not AI infrastructure.

The numbers behind the bet

The scale of the shift shows up most clearly in check size. Elevation's typical early-stage investment has moved from the $2M-to-$5M range up to as much as $10M per startup, according to data reported by Mint. That's roughly a doubling to tripling of the size of the first institutional check a founder might get, and it tells you two things at once: Elevation believes AI startups need more runway to reach product-market fit than a typical SaaS company did five years ago, and Elevation is competing harder for a shrinking pool of founders it considers differentiated. Inc42 reported that roughly two-thirds of Elevation's new investments over the past 18 months have already gone to AI-focused companies, so Fund IX formalizes a pattern the firm was already running, per Inc42's reporting.

Zoom out to the industry level and Elevation's move fits a pattern Bain & Company documented in its 2026 India venture capital report: the market has pivoted from the growth-at-all-costs posture that defined the 2021 boom toward monetization-led, AI-concentrated deployment. Firms are writing fewer checks into companies that can't show a path to revenue, and concentrating more capital into the AI names they believe can. That's a healthier posture for the asset class in the long run, but it also means the bar for what counts as a "differentiated" AI startup keeps rising just as more founders are entering the category. Elevation is betting it can clear that bar more often than its peers because of two decades of India-specific pattern recognition, not because AI itself is a novel edge.

The broader market backs up why Elevation is moving now. Indian AI startups raised $676M in the first half of 2026, more than four times the $162M raised in the first half of 2025, according to Inc42 data cited in the research behind this piece. Zoom into the first quarter alone and the headline number gets murkier: India AI funding hit $1.48B in Q1 2026, but roughly $1.2B of that was a single infrastructure deal, Neysa's raise backed by Blackstone. Strip that one deal out and organic AI funding across the rest of the market was closer to $280M spread across about 50 deals. That gap between the headline and the underlying number matters. It tells you the AI funding boom in India is still concentrated in a handful of large checks rather than broad-based, which is exactly the gap a $500M early-stage fund is designed to fill by writing more, and bigger, first checks to more founders.

Metric	Figure
Fund IX size (seed/Series A)	$500M
Elevation Holdings (late-stage)	$400M
Combined deployable capital	$900M
Typical early-stage check, old range	$2M-$5M
Typical early-stage check, new range	up to $10M
Indian AI startup funding, H1 2025	$162M
Indian AI startup funding, H1 2026	$676M
India AI funding, Q1 2026 (headline)	$1.48B
Of which, single Neysa/Blackstone deal	~$1.2B
Remaining organic Q1 2026 AI funding	~$280M across ~50 deals

What this means if you're an accredited investor, not a founder

You can't write a check into Fund IX directly unless you're already a limited partner in Elevation's fund family, and that door is closed to almost everyone reading this. So the practical question is: how does an individual accredited investor get exposure to the thesis Elevation just backed with $500M?

Start with what Elevation itself is not. It is not a public company, it does not list its LP terms, and unlike a U.S. venture firm raising a fund of similar size, there's no SEC Form D filing you can pull to see the minimum commitment or the LP roster. Tracxn's data on the firm, which puts assets under management above $2.6B across roughly 190 to 215 portfolio companies, gives you the closest thing to a public scorecard, and it's worth reading before you decide how much weight to put on any single fund announcement.

There are three real paths, and none of them is as clean as buying a fund. First, secondary markets: as Elevation's portfolio companies mature, some allow secondary share sales, and platforms that specialize in pre-IPO Indian tech equity occasionally surface stakes in companies like Meesho or Urban Company. This requires patience, accreditation-appropriate risk tolerance, and usually a minimum check well above what a typical retail investor would put into a single private position. Second, you can invest alongside the same thesis through India-focused venture funds of funds or feeder vehicles that some wealth platforms now offer to U.S. accredited investors, though due diligence on fees and lockups matters more here than the headline exposure. Third, and most accessible, you can track the public-market read-through: companies like Palo Alto Networks, which acquired Elevation portfolio company Portkey, give you a way to participate in the AI infrastructure consolidation trend without touching Indian private markets at all. None of these are a substitute for direct fund access, and I'd tell any client the same thing: this is thematic exposure, not a replication of Elevation's returns.

The Neysa comparison tells you where the real risk sits

The single most useful data point in this story isn't the $500M fund size. It's the Neysa deal. A $1.2B raise backed by Blackstone for AI infrastructure dwarfed the entire rest of the quarter's organic AI funding in India. That's a market structure where a small number of infrastructure-scale deals can make the aggregate numbers look far healthier than the founder-level reality. Elevation's bet is explicitly the opposite of the Neysa trade: it's betting on the app layer, meaning healthcare, education, fintech, and deeptech products built on top of existing models rather than the compute and infrastructure layer underneath them. Ravi Adusumalli and the Arora brothers, Mukul and Mridul, who lead Elevation, are wagering that India's durable AI value gets created by companies solving India-specific problems at India's scale and price points, not by companies trying to out-compute OpenAI or Anthropic. If you want a domestic comparison for how that bet has paid off before, look at Elevation's own book: Paytm and Swiggy were app-layer bets on Indian consumer behavior that took years and multiple down rounds before they worked, and Meesho is still working through its path to profitability years after Elevation's first check.

The honest risk case

I want to be direct about the part of this story that should make you cautious, because the research behind it surfaces a real warning, not a hypothetical one. Pankaj Tibrewal, a fund manager at IKIGAI Asset Management, has said publicly that current AI valuation, leverage, and capital concentration levels already exceed the excesses of the dot-com crash in 2000 and Japan's asset bubble in the 1980s. That's not a fringe voice. And the Reserve Bank of India has separately flagged AI valuation levels as a risk to financial stability, which is the kind of statement a central bank does not make lightly.

Layer that against Elevation's own numbers and you get a real tension. Two-thirds of the firm's recent deals are AI-focused, check sizes have doubled, and the fund is explicitly targeting companies without proven differentiation yet, because that's what seed and Series A investing is. If enterprise adoption in India doesn't keep pace with the capital being deployed, and if too many of these app-layer startups turn out to be thin wrappers around someone else's foundation model with no defensible moat, the realistic outcome by 2028 is a wave of shutdowns rather than a wave of unicorns. That's not me being contrarian for its own sake. It's the same math Elevation's own team has to be running internally, and it's why the firm is spreading $500M across many smaller-than-late-stage checks instead of concentrating it in a few large ones. Diversification across a fund is the standard hedge against exactly this failure mode, but it doesn't eliminate the risk that the whole cohort underperforms if the macro AI valuation correction that Tibrewal and the RBI are warning about actually arrives before these companies reach revenue scale.

What to do with this if you're deciding where to put capital

If you're an accredited investor looking at Indian AI exposure, treat Fund IX as a signal, not a product. The signal is that a firm with 25 years of India-specific pattern recognition and a 190-plus company portfolio just made its largest early-stage bet on app-layer AI, at higher check sizes, with institutional-grade due diligence behind every one of those decisions. That's useful information even if you can't buy into the fund itself. Use it to screen your own exposure: if you're evaluating a secondary stake, a feeder fund, or a public company with India AI exposure, ask the same question Elevation is implicitly asking of every founder it funds, which is whether the product has a defensible reason to exist beyond wrapping someone else's model. Ask for the retention numbers, the gross margin on AI inference costs, and the actual enterprise contract value, not the total addressable market slide. And size any single position as venture risk, not growth-equity risk, because at the seed and Series A stage that Fund IX is targeting, that's exactly what it is.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.